Orchid Cellmark to Announce Fourth Quarter and Year-End 2008 Financial Results on Marc...(seeking to verify parentage. Orchid Cel...),Health

Date:3/6/2009

seeking to verify parentage. Orchid Cellmark also serves immigration and security authorities for DNA testing of individuals. In the agriculture field, the company provides DNA testing services for selective trait breeding. Orchid Cellmark's strong market positions in these areas reflect the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the company's reputation for exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at www.orchidcellmark.com.

All statements in this press release that are not historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to the risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, risks and uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of Orchid Cellmark's products and services, dependence on government funding and collaborations, regulatory approvals, competition, intellectual property of others, patent protection, litigation, the timing of release of federal funds, the timing and amount of contracts put up for bid, and Orchid Cellmark's ability to successfully offer its services directly to U.K. police forces. These risks and other additional factors affecting these forward-looking statements and Orchid Cellmark's business are discussed under the headings "Risks Related to Our Business" and "Risks Associated with Our Common Stock" in Orchid Cellmark's Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the Securities and Exchange Commission, and in other filings made by Orchid Cellmark with the Securities and Exchange Commission from time to time. Orchid C
'/>"/>

SOURCE Orchid Cellmark Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3
Related medicine news :

1. Orchid Cellmark Reports Third Quarter 2008 Financial Results
2. Orchid Cellmark Reports Second Quarter 2008 Financial Results
3. Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008
4. Orchid Cellmark Reports First Quarter 2008 Financial Results
5. Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services
6. Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
7. Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
8. Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
9. Orchid Cellmark Reports Third Quarter 2007 Financial Results
10. Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date
11. Gaiam to Announce Fourth Quarter 2008 and Year End Results